Company

Our leadership

Dongwoo Kim, CEO

Dongwoo Kim, Ph.D.

Founder & Chief Executive Officer

Dongwoo founded AiderBio in 2025 after seven years of research in 3D cell culture and biomaterials. He leads the development of the Port Pocket culture platform and the company's disease model programs.

  • Ph.D., Applied Bioengineering, Seoul National University
  • 15+ peer-reviewed papers in biomaterials and disease modeling
  • Inventor on AiderBio's core patent applications
Selected publicationsJournalRole
3D in vitro synovial hyperplasia model for screening DMARDsMaterials Today Bio, 2024First author
ROS-sensitive SSZ-loaded ferrocene nanoparticles in a 3D synovial modelSmall, 2025First author
Multidimensional nanofibrous hydrogels integrated tri-culture systemBiofabrication, 2025First author
YAP is associated with disease severity and visual prognosis in ERMIOVS, 2025Co-author

Research Team

Seonghun Joo

Principal Researcher · M.S., Biomedical Engineering

Designs and fabricates the culture plates, and builds the imaging workflow and AI training data.

Yena Jeong

Senior Researcher · M.S., Pharmacy

Leads 3D organoid modeling, drug treatment and monitoring of drug response.

Eungseo Lee

Manager · Business Operations

Runs business operations, project administration and partner communication.

Contact AiderBio

We welcome research collaborations, PoC studies, OrganoKit sample requests and partnership inquiries from pharma, CROs, hospitals and academic labs.

qaz8949@aiderbio.com